What trends show in INSP's 2024 earnings growth?

Inspire Medical (INSP) demonstrated robust earnings growth in 2024, driven by a significant increase in net income and diluted EPS, with strong quarterly performances throughout the year.

1. **Net Income Growth**: Inspire Medical's net income grew by 3.53% as of December 31, 2024, reaching $53.51 million. This substantial growth highlights the company's financial performance and ability to generate profits.

|code|Ticker|Name|Date|Net Income YoY|market_code|
|---|---|---|---|---|---|
|INSP|INSP.N|Inspire Medical|2024 Q1|35.133558091286304|169|
|INSP|INSP.N|Inspire Medical|2024 Q2|181.936077643909|169|
|INSP|INSP.N|Inspire Medical|2024 Q3|316.59250585480095|169|
|INSP|INSP.N|Inspire Medical|2024 Q4|138.5964912280702|169|

2. **Earnings Per Share (EPS) Growth**: The diluted EPS also experienced a notable increase, growing by 3.43% as of December 31, 2024, reaching $1.75. This indicates that not only the net income but also the earnings per share contributed to the overall growth of the company.

|code|Ticker|Name|Date|Diluted EPS YoY|market_code|
|---|---|---|---|---|---|
|INSP|INSP.N|Inspire Medical|2024 Q1|35.84905660377358|169|
|INSP|INSP.N|Inspire Medical|2024 Q2|178.0487804878049|169|
|INSP|INSP.N|Inspire Medical|2024 Q3|306.8965517241379|169|

3. **Quarterly Earnings Trends**: Inspire Medical's earnings growth was consistent across all four quarters of 2024, with earnings release dates on March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024. This consistent performance underscores the company's strong financial trajectory throughout the year.

In conclusion, Inspire Medical's 2024 earnings growth is marked by strong net income and EPS increases, with a consistent performance across all quarters, reflecting the company's solid financial performance and growth prospects.